Weight Loss With Subcutaneous Semaglutide Versus Other Glucagon Like Peptide-1 Receptor Agonists In Type 2 Diabetes: A Systematic Review

- Stretton, Brandon, Kovoor, Joshua, Maddern, Guy, Thompson, Campbell H., Heilbronn, Leonie, Boyd, Mark, Rayner, Christopher, Talley, Nicholas J., Horowtiz, Michael, Bacchi, Stephen, Chang, Shantel, Ngoi, Benjamin, Murray, Tess, Bristow, Thomas C., Heng, Jonathan, Gupta, Aashray, Ovenden, Christopher

Do medical oncology patients and their support persons agree about end of life issues?

- Waller, Amy, Hall, Alix, Sanson-Fisher, Rob, Zdenkowski, Nicholas, Douglas, Charles, Walsh, Justin

Individualised medicine: why we need Bayesian dosing

- Donagher, Joni, Martin, Jennifer H., Barras, Michael A.

Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities

- Gedye, C., van der Westhuizen, A., John, T.

Enrolment of patients to clinical trials in haematological cancer in New South Wales: current status, perceived barriers and opportunities for improvement

- Murray, P., Kerridge, I., Tiley, C., Catanzariti, A., Welberry, H., Lean, C., Sinclair, S., Bishop, J., Bradstock, K.

Serum testosterone levels correlate with haemoglobin in middle-aged and older men

- Yeap, B. B., Beilin, J., Shi, Z., Knuiman, M. W., Olynyk, J. K., Bruce, D. G., Milward, E. A.